Michael Deligny et al.
COMMUNICATIONS
of solvent, the residue was taken up in 10 mL of THF. At 08C,
676 mL (6.76 mmol) of H2O2 35% w/w in water and 2.2 mL
(6.76 mmol) of 3 M NaOH were successively added. After
stirring for one hour at 08C, the mixture was saturated with
solid K2CO3 and stirred for 30 min. The mixture was extracted
with ether and dried over anhydrous MgSO4, filtered and
concentrated under vacuum. The crude product was purified
by column chromatography (heptane/AcOEt, 1/1) on SiO2
deactivated with triethylamine to afford 4; yield: 222 mg
(1.59 mmol, 95%). 1H NMR (CDCl3): d 1.28 (t, 3H, J
7.1 Hz), 1.94 (m, 4H), 3.54 (m, 3H), 3.83 (dq, 1H, J 9.7,
7.1 Hz), 4.07 (m, 2H), 4.81 (t, 1H, J 3.1 Hz); 13C NMR
(CDCl3): d 15.5 (CH3), 33.2 (CH2), 37.1 (CH2), 56.2 (CH2),
64.2 (CH2), 64.6 (CH), 98.3 (CH); [a]D25: 43.1 (c 1.00, CHCl3).
(CH), 128.5 (CH), 128.6 (CH), 133.7 (C), 138.6 (C). Anal calcd.
for C14H17ClO3: C 62.57, H 6.38; found: C 62.76, H 6.81. [a]D25:
48.4 (c 1.00, CHCl3). Assay of enantiomeric excess: Chiral
GC analysis (Chirasil-dex; 80 to 1008C at 58C/min, then 100 to
1808C at 18C/min, 10 psi head column pressure; tR(major)
86.62 min, tR(minor) 85.58 min).
(2S,6R,7R)-3,6-Dihydro-2H-pyran (5d): yield: 80%
1
(202 mg, 0.80 mmol). H NMR (CDCl3): d 1.30 (t, 3H, J
7.1 Hz), 2.31 (m, 2H), 3.43 (br d, 1H, J 2.2 Hz), 3.67 (dq, 1H,
J 9.5, 7.1 Hz), 4.06 (dq, 1H, J 9.5, 7.1 Hz), 4.36 (m, 1H), 4.65
(dd, 1H, J 7.3, 2.2 Hz), 4.83 (t, 1H, J 5.4 Hz), 5.44 (m, 1H),
5.83 (m, 1H), 7.09 (m, 2H), 7.44 (m, 2H); 13C NMR (CDCl3):
d 15.2 (CH3), 31.0 (CH2), 64.6 (CH2), 76.2 (CH), 78.7 (CH),
98.5 (CH), 115.0 (CH), 115.4 (CH), 125.1 (CH), 125.4 (CH),
128.8 (CH), 129.0 (CH), 136.2 (C), 136.3 (C), 160.0 (C), 164.0
.
À
(C); HRMS (EI): [M OCH2CH3] , calcd. for C12H12FO2:
207.0821; found: 207.083. Anal calcd. for C14H17FO3: C 68.16, H
7.63; found: C 68.16, H 7.81. [a]D25: 13.7 (c 1.00, CHCl3). Assay
of enantiomeric excess: Chiral GC analysis (Chirasil-dex; 80 to
1008C at 58C/min, then 100 to 1808C at 18C/min, 10 psi head
General Procedure for the Allylboration Reactions
A solution of 1 mmol of 3 and 2 mmol of aldehyde in 2 mL of
toluene was heated at 708C. The reaction was monitored by
GC and allowed to stir until complete consumption of 3. After
addition of a saturated solution of NH4Cl, the aqueous layer
was extracted twice with CH2Cl2. Combined organic layers
were washed with saturated NaCl, dried over anhydrous
MgSO4, filtered and concentrated under vacuum. The crude
product was purified by column chromatography (heptane/
AcOEt, 9/1) on SiO2 deactivated with triethylamine to yield
5a g as indicated in Table 1.
column
68.70 min).
pressure;
tR(major) 69.88 min,
tR(minor)
(2S,6R,7R)-3,6-Dihydro-2H-pyran (5e): yield: 82%
1
(203 mg, 0.82 mmol). H NMR (CDCl3): d 1.25 (t, 3H, J
7.1 Hz), 2.30 (m, 2H), 2.60 (br d, 1H, J 6.6 Hz), 3.00 (m, 2H),
3.66 (dq, 1H, J 9.5, 7.1 Hz), 3.88 (m, 1H), 4.09 (dq, 1H, J 9.5,
7.1 Hz), 4.20 (m, 1H), 4.80 (t, 1H, J 5.4 Hz), 5.70 (m, 1H), 5.89
(m, 1H), 7.31 (m, 5H); 13C NMR (CDCl3): d 15.7 (CH3), 31.4
(CH2), 40.0 (CH2), 64.9 (CH2), 74.7 (CH), 75.7 (CH), 98.9
(CH), 125.4 (CH), 126.6 (CH), 126.9 (CH), 128.9 (CH), 129.8
(2S,6R,7R)-3,6-Dihydro-2H-pyran (5a): yield: 85%
1
(198 mg, 0.85 mmol). H NMR (CDCl3): d 1.31 (t, 3H, J
]
À
(CH), 138.9 (C); HRMS (EI): [M HOC2H5 , calcd. for
7.1 Hz), 2.30 (m, 2H), 3.00 (br s, 1H), 3.62 (dq, 1H, J 9.6,
7.1 Hz), 4.05 (dq, 1H, J 9.6, 7.1 Hz), 4.39 (m, 1H), 4.61 (d, 1H,
J 7.5 Hz), 4.82 (t, 1H, J 5.4 Hz), 5.42 (m, 1H), 5.80 (m, 1H),
7.40 (m, 5H); 13C NMR (CDCl3): d 15.6 (CH3), 31.4 (CH2),
64.9 (CH2), 77.2 (CH), 79.1 (CH), 98.9 (CH), 125.3 (CH), 125.8
(CH), 127.7 (CH), 128.5 (CH), 128.8 (CH), 140.3 (C); HRMS
C13H14O2: 202.0994; found: 202.099. [a]D25: 23.7 (c 1.00,
CHCl3). Assay of enantiomeric excess: Chiral GC analysis
(Chirasil-dex; 80 to 1008C at 58C/min, then 100 to 1808C at
18C/min, 10 psi head column pressure; tR(major) 75.93 min,
tR(minor) 76.66 min).
.
(2S,6R,7R)-3,6-Dihydro-2H-pyran (5f): yield: 87%
À
À
(EI): [M CHOH Ph] , calcd. for C7H11O2: 127.0759; found:
127.076; [a]D25: 24.9 (c 1.03, CHCl3). Assay of enantiomeric
excess: Chiral GC analysis (Chirasil-dex; 80 to 1008C at 58C/
min, then 100 to 1808C at 18C/min, 10 psi head column
pressure; tR(major) 68.37 min, tR(minor) 68.74 min).
(2S,6R,7R)-3,6-Dihydro-2H-pyran (5b): yield: 84%
1
(228 mg, 0.87 mmol). H NMR (CDCl3): d 1.17 (t, 3H, J
7.1 Hz), 1.82 (m, 2H), 2.15 (m, 2H), 2.60 (br d, 1H, J 5.8 Hz),
2.64 (m, 1H), 2.81 (m, 1H), 3.47 (m, 2H), 3.89 (dq, 1H, J 9.5,
7.1 Hz), 4.08 (m, 1H), 4.66 (dd, 1H, J 5.4, 6.0 Hz), 5.54 (m,
1H), 5.74 (m, 1H), 7.14 (m, 5H); 13C NMR (CDCl3): d 15.2
(CH3), 31.0 (CH2), 32.0 (CH2), 35.0 (CH2), 64.4 (CH2), 72.6
(CH), 77.3 (CH), 98.5 (CH), 124.9 (CH), 125.8 (CH), 126.5
(CH), 128.4 (CH), 128.5 (CH), 142.2 (C); HRMS (EI):
1
(221 mg, 0.84 mmol). H NMR (CDCl3): d 1.28 (t, 3H, J
7.1 Hz), 2.29 (m, 2H), 3.40 (br s, 1H), 3.64 (dq, 1H, J 9.5,
7.0 Hz), 3.84 (s, 3H), 4.06 (dq, 1H, J 9.5, 7.0 Hz), 4.38 (m, 1H),
4.63 (d, 1H, J 7.8 Hz), 4.83 (t, 1H, J 5.4 Hz), 5.39 (m, 1H),
5.82 (m, 1H), 6.96 (d, 2H, J 8.7 Hz), 7.35 (d, 2H, J 8.7 Hz);
13C NMR (CDCl3): d 15.2 (CH3), 31.1 (CH2), 64.5 (CH2), 76.5
(CH), 78.9 (CH), 98.6 (CH), 113.8 (CH3), 124.8 (CH), 125.5
À
[M HOC2H5] , calcd. for C14H16O2: 216.1150; found: 216.115.
[a]D25: 70.7 (c 1.00, CHCl3). Assay of enantiomeric excess:
Chiral GC analysis (Chirasil-dex; 80 to 1008C at 58C/min, then
100 to 1808C at 18C/min, 15 psi head column pressure;
tR(major) 82.16 min, tR(minor) 81.35 min).
.
(CH), 128.6 (CH), 132.0 (C), 159.4 (C); HRMS (EI): [M] ,
calcd. for C15H20O4: 264.1362; found: 264.136. [a]D25: 76.4 (c
1.02, CHCl3). Assay of enantiomeric excess: Chiral GC analysis
(Chirasil-dex; 80 to 1008C at 58C/min, then 100 to 1808C at
18C/min, 10 psi head column pressure; tR(major) 75.00 min,
tR(minor) 74.31 min).
(2S,6R,7S,8R)-3,6-Dihydro-2H-pyran (5g): mp 1398C;
1
yield: 78% (391 mg, 0.78 mmol). H NMR (CDCl3): d 1.02
(s, 9H), 1.18 (t, 3H, J 7.1 Hz), 2.19 (m, 2H), 2.47 (d, 1H, J
7.9 Hz), 3.30 (dq, 1H, J 9.5, 7.1 Hz), 3.72 (dq, 1H, J 9.5,
7.1 Hz), 3.78 (td, 1H, J 7.8, 2.6 Hz), 4.63 (dd, 1H, J 6.1,
4.6 Hz), 4.73 (m, 1H), 4.82 (d, 1H, J 7.6 Hz), 5.63 (m, 1H),
5.80 (m, 1H), 7.40 (m, 13H), 7.68 (dd, 2H, J 7.8, 1.4 Hz);
13C NMR (CDCl3): d 15.5 (CH3), 19.8 (C), 27.4 (CH3), 31.2
(CH2), 64.6 (CH2), 73.5 (CH), 76.3 (CH), 77.3 (CH), 98.4 (CH),
124.9 (CH), 127.9 (CH), 127.6 (CH), 127.8 (CH), 128.2 (CH),
128.4 (CH), 129.8 (CH), 129.9 (CH), 136.4 (CH), 136.5 (CH),
133.7 (C), 134.4 (C), 141.7 (C). [a]D25: 39.3 (c 1.04, CHCl3.
(2S,6R,7R)-3,6-Dihydro-2H-pyran (5c): yield: 77%
1
(207 mg, 0.77 mmol). H NMR (CDCl3): d 1.26 (t, 3H, J
7.1 Hz), 2.26 (m, 2H), 3.30 (br s, 1H), 3.58 (dq, 1H, J 9.6,
7.1 Hz), 3.98 (dq, 1H, J 9.6, 7.1 Hz), 4.32 (m, 1H), 4.61 (d, 1H,
J 7.0 Hz), 4.79 (t, 1H, J 5.5 Hz), 5.38 (m, 1H), 5.84 (m, 1H),
7.33 (m, 4H); 13C NMR (CDCl3): d 15.2 (CH3), 30.9 (CH2),
64.5 (CH2), 76.0 (CH), 78.4 (CH), 98.4 (CH), 125.1 (CH), 125.2
1218
¹ 2003 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
asc.wiley-vch.de
Adv. Synth. Catal. 2003, 345, 1215 1219